Monopar Therapeutics IncMonopar Therapeutics IncMonopar Therapeutics Inc

Monopar Therapeutics Inc

No trades
See on Supercharts

Price target

48.000.000.00%
The 4 analysts offering 1 year price forecasts for A40JML have a max estimate of — and a min estimate of —.

Analyst rating

Based on 4 analysts giving stock ratings to A40JML in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


A40JML EPS for the last quarter is −0.33 EUR despite the estimation of −0.89 EUR. In the next quarter EPS is expected to reach −0.35 EUR. Track more of Monopar Therapeutics Inc financials and stay on top of what is up with the company.
In the next quarter Monopar Therapeutics Inc revenue is expected to reach 0.00 EUR. Check out Monopar Therapeutics Inc revenue and earnings and make informed decisions.
According to analysts, A40JML price target is 48.00 EUR with a max estimate of 63.06 EUR and a min estimate of 34.82 EUR. Check if this forecast comes true in a year, meanwhile watch Monopar Therapeutics Inc stock price chart and keep track of the current situation with A40JML news and stock market news.